Literature DB >> 17404476

[Osteoclast differentiation and activation].

Hiroshi Takayanagi1.   

Abstract

In autoimmune arthritis, activation of T cells induces bone destruction through receptor activator of NF-kappaB ligand (RANKL) . Recent study revealed interleukin-17 (IL-17) -producing helper T cell subset (Th17) , but not IFN-gamma-producing Th1, to be responsible for bone destruction. Here we summarize the current understanding of osteoclast differentiation and activation in the context of osteoimmunology.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17404476     DOI： CliCa0704484492

Source DB:  PubMed          Journal:  Clin Calcium        ISSN： 0917-5857


  11 in total

Review 1.  Effect of inflammation on bones in diabetic patients with periodontitis via RANKL/OPG system-A review.

Authors:  Hira Ateeq; Afaf Zia; Qayyum Husain; Mohd Sajid Khan; Mohd Ahmad
Journal:  J Diabetes Metab Disord       Date:  2022-01-29

Review 2.  Aloperine: A Potent Modulator of Crucial Biological Mechanisms in Multiple Diseases.

Authors:  Muhammad Tahir; Sakhawat Ali; Wenting Zhang; Boqiang Lv; Wenge Qiu; Juan Wang
Journal:  Biomedicines       Date:  2022-04-15

3.  The Dibenzyl Isoquinoline Alkaloid Berbamine Ameliorates Osteoporosis by Inhibiting Bone Resorption.

Authors:  Chongjing Zhang; Zeyuan Zhong; Weicong Sang; Farnaz Ghorbani; Behafarid Ghalandari; Marjan Mohamadali; Shiva Irani; Zhi Qian; Chengqing Yi; Baoqing Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-18       Impact factor: 6.055

4.  Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB.

Authors:  Gui-Hua Quan; Hongbing Wang; Jinjin Cao; Yuxin Zhang; Donglin Wu; Qisheng Peng; Ning Liu; Wan-Chun Sun
Journal:  Int J Mol Sci       Date:  2015-12-10       Impact factor: 5.923

5.  Genome-Wide Association Identifies Risk Pathways for SAPHO Syndrome.

Authors:  Ruikun Cai; Yichao Dong; Mingxia Fang; Yuxuan Fan; Zian Cheng; Yue Zhou; Jianen Gao; Feifei Han; Changlong Guo; Xu Ma
Journal:  Front Cell Dev Biol       Date:  2021-03-18

Review 6.  The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis.

Authors:  Wacili Da; Lin Tao; Yue Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-12       Impact factor: 5.555

7.  Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation.

Authors:  Fangbing Zhu; Jianyue Wang; Yueming Ni; Wei Yin; Qiao Hou; Yingliang Zhang; Shigui Yan; Renfu Quan
Journal:  J Immunol Res       Date:  2021-07-04       Impact factor: 4.818

8.  Oxymatrine Attenuates Osteoclastogenesis via Modulation of ROS-Mediated SREBP2 Signaling and Counteracts Ovariectomy-Induced Osteoporosis.

Authors:  Chao Jiang; Qingliang Ma; Shiyu Wang; Yang Shen; An Qin; Shunwu Fan; Zhiwei Jie
Journal:  Front Cell Dev Biol       Date:  2021-05-31

Review 9.  An Evidence-Based Update on the Molecular Mechanisms Underlying Periodontal Diseases.

Authors:  Syed Saad B Qasim; Dalal Al-Otaibi; Reham Al-Jasser; Sarhang S Gul; Muhammad Sohail Zafar
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

10.  Osteoporosis Remission and New Bone Formation with Mesoporous Silica Nanoparticles.

Authors:  Patricia Mora-Raimundo; Daniel Lozano; Manuel Benito; Francisca Mulero; Miguel Manzano; María Vallet-Regí
Journal:  Adv Sci (Weinh)       Date:  2021-06-06       Impact factor: 16.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.